The manufacturers of the blood thinner Xarelto are facing more than 9,000 lawsuits filed on behalf of patients who suffered excessive bleeding events linked to the drug. More than 7,000 Xarelto lawsuits against Bayer and Janssen Pharmaceuticals have been filed in Louisiana alone. Additional lawsuits have also been filed in Pennsylvania and Delaware.
The U.S. District Court judge overseeing the Xarelto lawsuits filed against Bayer in Louisiana has designated four “bellwether” cases that are set to go to trial in 2017. The cases are scheduled to be tried in Mississippi, Texas, and Louisiana.
Lawsuits filed against Bayer and Janssen allege that patients who were treated with Xarelto suffered severe bleeding events. Xarelto was developed as an alternative to the popular bloodthinner, warfarin. Although patients treated with Xarelto are forced to undergo fewer blood tests in order to take the drug, unlike warfarin, Xarelto has no antidote that can be used to stop excessive bleeding events. As a result, patients treated with Xarelto may be at risk of potentially fatal bleeding incidents.
Over recent years, Xarelto accounted for more cases involving serious injuries than any other drug regularly monitored by federal health authorities. According to data from the Food and Drug Administration, in 2015 there were 10,674 reports of injuries reported among patients treated with Xarelto. These cases included 1,121 patient deaths and 4,508 cases requiring hospitalization.
The first Xarelto bellwether trial, which is scheduled to go to trial in February 2017, involves a Louisiana man who alleges that he developed severe gastrointestinal bleeding after being treated with the drug. The second bellwether lawsuit – which will also be tried in Louisiana – was filed by the husband of a woman who was treated with Xarelto for a month before she died of a brain hemorrhage.
Two other Xarelto bellwether trials are scheduled to be heard in Mississippi and Texas. The Mississippi trial involves a woman from that state who allegedly developed intestinal bleeding after being treated for blood clots with Xarelto. The Texas case involves a man from that state who died from gastrointestinal bleeding after being treated with Xarelto.
Xarelto Lawsuits Filed on Behalf of Patients Affected by Severe Bleeding Incidents
Patients who have suffered gastrointestinal bleeding or other serious bleeding events linked to Xarelto may be eligible to file a lawsuit. If you or a loved one have suffered gastrointestinal bleeding or other severe bleeding events caused by Xarelto, you may be able to receive compensation for medical expenses and other losses caused by these injuries. The first step in taking legal action is to speak with an experienced attorney who can help guide you through the process of filing a claim and advise you regarding your legal rights.
Heygood, Orr & Pearson has already filed several lawsuits on behalf of patients who were injured after taking the blood thinners Pradaxa or Xarelto. Our lawyers have also handled numerous other pharmaceutical liability cases. Heygood, Orr & Pearson has handled more cases involving the fentanyl pain patch than all other law firms in the country combined, and have filed numerous lawsuits on behalf of patients who were injured after taking Yasmin, Actos, Avandia, Zofran, and other prescriptions drugs.
The law firm of Heygood, Orr & Pearson has filed hundreds of lawsuits on behalf of patients who were injured by dangerous drugs or other medical products. Our attorneys have tried hundreds of cases to verdict and have achieved settlements in hundreds more on behalf of our clients. At Heygood, Orr & Pearson, we believe that when pharmaceutical companies manufacture dangerous drugs or medical devices, they should be held responsible for the injuries caused by these products in a court of law.
For more information about the Xarelto litigation and to receive a free consultation to learn whether you may qualify to file a case, contact the lawyers at Heygood, Orr & Pearson by calling toll-free at 1-877-446-9001. You can also reach us by following this link to our free case evaluation form and answering a few brief questions to get started.